Articles in section Mergers & Acquisitions
| << Licensing | 713 articles | Opinion & Analysis >> |
| Pages 1 2 3 4 5 .. 72 | Next >> |
-
Chiesi Expands Global Rare Disease Portfolio with US$1.9 B Acquisition of KalVista Pharmaceuticals
-
Lilly Acquires Kelonia Therapeutics for US$7 B to Expand In Vivo CAR T Capabilities
-
Sun Pharma to Acquire Organon for US$11.75 B
-
Neurocrine Biosciences Expands Rare Disease Portfolio with US$2.9 B Acquisition of Soleno Therapeutics
-
UCB Strengthens Epilepsy Portfolio with US$1.15 B Acquisition of Neurona Therapeutics
-
Gilead to Acquire ADC Specialist Tubulis for US$5 B
-
Merck & Co. Expands Haematology Portfolio with US$6.7 B Acquisition of Terns Pharmaceuticals
-
Lilly Pays US$2.4 B to Acquire Orna Therapeutics and its CAR-T Cell Therapies for Autoimmune Diseases
-
GSK to Acquire RAPT Therapeutics for up to US$2.2 B
-
Lilly to Acquire Ventyx Biosciences for US$1.2 B to Advance Oral Therapies Targeting Inflammatory-Mediated Diseases
RSS